Clinical Trials Browser

Phase 1 × Interventional × Osteomalacia × Clear all

NCT01748812 2018-07-05

Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

Phase 1 Terminated

Oncogenic osteomalacia, Osteomalacia, Rickets, Hypophosphatemic